Related Articles
EGF ligand fused to truncated Pseudomonas aeruginosa exotoxin A specifically targets and inhibits EGFR‑positive cancer cells
THE GROWTH-RESPONSE OF HUMAN TUMOR-CELL LINES EXPRESSING THE EGF RECEPTOR TO TREATMENT WITH EGF AND OR MABS THAT BLOCK LIGAND-BINDING
Monoclonal antibodies directed against the EGF receptor show differential bindings of amphiregulin and EGF to the EGF receptor
EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
INHIBITION OF PROLIFERATION, ACTIVATION AND FUNCTION OF HUMAN NATURAL-KILLER-CELLS IN-VITRO BY SECRETED PRODUCTS OF LOVO, A COLORECTAL-CANCER CELL-LINE